European Disease Progression Monitor: Edition 5 | L.E.K. Consulting

European Disease Progression Monitor: Edition 5

COVID-19 EU progression monitor

lockdown exit strategies in EU

lockdown transition plan

COVID-19 death rate EU

tracking the pandemic

control phase

French data

U.K. numbers have stabilised

Overview of treatments

Disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition 4

Sign-up here to receive Disease Progression Monitor updates.

Sign-up

Related Insights

Life Sciences & Pharma

Executive Insights

AI in Life Sciences: Emerging Business Models

April 24, 2020

The presence of artificial intelligence (AI) in life sciences is growing quickly as a result of multiple AI companies focusing on drug discovery and…

Biotech and Pharmaceuticals

Published Articles

5 Essential Factors For A Successful Biopharma Product Launch

October 23, 2019

Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully.

MedTech

COVID-19

Strategic Hospital Priorities in APAC – Emerging Themes and Implications for Medtechs

April 1, 2020

With the COVID-19 crisis putting pressure on our healthcare systems, some short-term priorities will have obviously changed.

MedTech

COVID-19

COVID-19 and the Acceleration of Digital Health in APAC

April 23, 2020

Healthcare stakeholders are implementing drastic measures, including swift deployment of digital health tools, in an effort to curb the spread of the…

Life Sciences & Pharma

COVID-19

COVID-19 and Clinical Trials: Accelerating the Adoption of eClinical Technology

April 2, 2020

Interruptions to trial timelines are occurring with increasing frequency as sponsors and investigator sites feel the effects of the COVID-19 outbreak.

Biotech and Pharmaceuticals

Executive Insights

What Drug Price Controls in Malaysia Mean for the Pharmaceutical Industry

May 30, 2019

On May 2, the Malaysian Cabinet announced that price control measures for pharmaceutical drugs would be implemented in 2019. With mentions of “external…